Comparison of the EGFR resistance mutation profiles generated by EGFR-targeted tyrosine kinase inhibitors and the impact of drug combinations

E Avizienyte, RA Ward, AP Garner - Biochemical Journal, 2008 - portlandpress.com
Recent clinical data indicates that the emergence of mutant drug-resistant kinase alleles
may be particularly relevant for targeted kinase inhibitors. In order to explore how different …

Comparison of the EGFR resistance mutation profiles generated by EGFR-targeted tyrosine kinase inhibitors and the impact of drug combinations

E Avizienyte, RA Ward, AP Garner - Biochemical Journal, 2008 - cir.nii.ac.jp
抄録< jats: p> Recent clinical data indicates that the emergence of mutant drug-resistant
kinase alleles may be particularly relevant for targeted kinase inhibitors. In order to explore …

Comparison of the EGFR resistance mutation profiles generated by EGFR-targeted tyrosine kinase inhibitors and the impact of drug combinations

E Avizienyte, RA Ward… - The Biochemical …, 2008 - pubmed.ncbi.nlm.nih.gov
Recent clinical data indicates that the emergence of mutant drug-resistant kinase alleles
may be particularly relevant for targeted kinase inhibitors. In order to explore how different …

[PDF][PDF] Comparison of the EGFR resistance mutation profiles generated by EGFR targeted tyrosine kinase inhibitors and the impact of drug combinations

E Avizienyte, RA Ward, AP Garner - 2008 - researchgate.net
Recent clinical data indicates that the emergence of mutant drug-resistant kinase alleles
may be particularly relevant for targeted kinase inhibitors. In order to explore the how …

Comparison of the EGFR resistance mutation profiles generated by EGFR-targeted tyrosine kinase inhibitors and the impact of drug combinations.

E Avizienyte, RA Ward, AP Garner - The Biochemical Journal, 2008 - europepmc.org
Recent clinical data indicates that the emergence of mutant drug-resistant kinase alleles
may be particularly relevant for targeted kinase inhibitors. In order to explore how different …

Comparison of the EGFR resistance mutation profiles generated by EGFR-targeted tyrosine kinase inhibitors and the impact of drug combinations

E Mcdonald, E Avizienyte, RA Ward… - Biochemical …, 2008 - research.manchester.ac.uk
Recent clinical data indicates that the emergence of mutant drug-resistant kinase alleles
may be particularly relevant for targeted kinase inhibitors. In order to explore how different …

Comparison of the EGFR resistance mutation profiles generated by EGFR-targeted tyrosine kinase inhibitors and the impact of drug combinations

E AVIZIENYTE, A Richard, AP GARNER - Biochem. J, 2008 - portlandpress.com
Recent clinical data indicates that the emergence of mutant drugresistant kinase alleles may
be particularly relevant for targeted kinase inhibitors. In order to explore how different …

[PDF][PDF] Comparison of the EGFR resistance mutation profiles generated by EGFR targeted tyrosine kinase inhibitors and the impact of drug combinations

E Avizienyte, RA Ward, AP Garner - 2008 - academia.edu
Recent clinical data indicates that the emergence of mutant drug-resistant kinase alleles
may be particularly relevant for targeted kinase inhibitors. In order to explore the how …

Comparison of the EGFR resistance mutation profiles generated by EGFR targeted tyrosine kinase inhibitors and the impact of drug combinations

E Avizienyte, RA Ward, AP Garner - Biochemical Journal, 2008 - hal.science
Recent clinical data indicates that the emergence of mutant drug-resistant kinase alleles
may be particularly relevant for targeted kinase inhibitors. In order to explore the how …

[PDF][PDF] Comparison of the EGFR resistance mutation profiles generated by EGFR targeted tyrosine kinase inhibitors and the impact of drug combinations

E Avizienyte, RA Ward, AP Garner - 2008 - academia.edu
Recent clinical data indicates that the emergence of mutant drug-resistant kinase alleles
may be particularly relevant for targeted kinase inhibitors. In order to explore the how …